Select Page
New HKEx Guidance for Biotech Companies Listing under Chapter 18A

Hong Kong Law

July 2020

Boutique Transactional Law Firm of the Year 2017

Asian Legal Business Awards

This newsletter is for information purposes only.

Its contents do not constitute legal advice and it should not be regarded as a substitute for detailed advice in individual cases.
Transmission of this information is not intended to create and receipt does not constitute a lawyer-client relationship between Charltons and the user or browser.
Charltons is not responsible for any third party content which can be accessed through the website.

If you do not wish to receive this newsletter please let us know by emailing us at unsubscribe@charltonslaw.com

Charltons
Dominion Centre,12th Floor
43-59 Queen’s Road East Hong Kong

Tel: + (852) 2905 7888
Fax: + (852) 2854 9596
www.charltonslaw.com

 
Charltons - Hong Kong Law - 510 - 22 July 2020

Listing Biotech Companies

Suitability for Listing Biotech Companies

Listing document Disclosure Biotech Companies

Chapter 18A listing

Suitability for Listing Biotech Companies Hong Kong

Guidance listing biotech companies HKEx

Guidance Letter HKEx-GL92-18

Guidance Letter HKEx-GL107-20

Subscription of IPO Shares by existing shareholders Biotech Companies

Main Board Listing Rule 18A.03(1) suitability criteria
Prospectus disclosure requirements for Chapter 18A listings
Hong Kong Stock Exchange pre-revenue biotech listings
Frequently asked questions on listing regime for companies from emerging and innovative sectors